SCHEMBL3479971

SCHEMBL3479971

CCO[Si](OCC)(OCC)C1c2ccccc2-c2ccccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.38
BCHE P06276 1/20 0.38
GPR3 P46089 2/20 0.38
HTR2A P28223 1/20 0.38
CYP1A2 P05177 2/20 0.37
TSHR P16473 2/20 0.37
CYP2C19 P33261 1/20 0.37
POLB P06746 2/20 0.36
CHRM2 P08172 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35
CHRM1 P11229 1/20 0.35
DRD1 P21728 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
ADRA1A P35348 1/20 0.35
OPRM1 P35372 1/20 0.35
DRD3 P35462 1/20 0.35
SLC6A3 Q01959 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2551833 0.85 ACHE (0.40) ACHEBCHEGPR3HTR2ACYP1A2
SCHEMBL7546246 0.82 ACHE (0.37) ACHEBCHEGPR3HTR2ACYP1A2
SCHEMBL1985428 0.77 GPR3 (0.41) ACHEBCHEGPR3HTR2ACYP1A2
SCHEMBL6673985 0.72 GPR3 (0.41) ACHEBCHEGPR3HTR2APOLB
SCHEMBL7583449 0.72 GPR3 (0.41) ACHEBCHEGPR3HTR2APOLB
SCHEMBL2549562 0.72 POLB (0.38) ACHEBCHEGPR3HTR2ACYP1A2
SCHEMBL7577807 0.69 ACHE (0.43) ACHEBCHEGPR3HTR2APOLB
SCHEMBL5175634 0.69 GPR3 (0.46) ACHEBCHEGPR3HTR2ACYP1A2
SCHEMBL6671925 0.69 GPR3 (0.46) ACHEBCHEGPR3HTR2ACYP1A2
SCHEMBL30390148 0.69 GPR3 (0.46) ACHEBCHEGPR3HTR2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107076894-B Infrared shielding composition, cured film, and solid-state imaging device JSR株式会社 2020-01-31 CN disclosed
EP-2239301-B1 SILOXANE RESIN COMPOSITIONS TORAY INDUSTRIES (JP) 2016-04-27 EP disclosed
US-8389649-B2 Siloxane-based resin composition TORAY INDUSTRIES, INC. (JP) 2013-03-05 US disclosed
US-20100316953-A1 SILOXANE-BASED RESIN COMPOSITION TORAY INDUSTRIES, INC. (JP) 2010-12-16 US disclosed
EP-2239301-A1 SILOXANE RESIN COMPOSITIONS Toray Industries, Inc. (JP) 2010-10-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100316953-A1 SILOXANE-BASED RESIN COMPOSITION ICAM1, ESD, CAD ACHE 1462/4885BCHE 2377/4885GPR3 2634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.